Crinetics Pharmaceuticals, Inc. (CRNX) Financials

CRNX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 1.3 billion 129.9 million
March 31, 2026 1.4 billion 120.7 million
Dec. 31, 2025 1.1 billion 143.4 million
Sept. 30, 2025 1.2 billion 123.9 million

CRNX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -94.7 million 24.9 million
March 31, 2026 -125.5 million 29.7 million
Dec. 31, 2025 -93.4 million 21.7 million
Sept. 30, 2025 -111.6 million 22.7 million

CRNX Net Income

No data available :(

CRNX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 1.2 billion - 47.2 million
March 31, 2026 1.3 billion - 41.3 million
Dec. 31, 2025 1.0 billion - 42.1 million
Sept. 30, 2025 1.1 billion - 49.1 million

CRNX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 105.6 million
March 31, 2026 104.1 million
Dec. 31, 2025 94.1 million
Sept. 30, 2025 94.2 million

CRNX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 521000 99.9 million 57.6 million -
March 31, 2026 820000 100.1 million 50.8 million -
Dec. 31, 2025 458000 85.1 million 53.7 million -
Sept. 30, 2025 863000 90.5 million 52.3 million -

CRNX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 25.1 million 154000
March 31, 2026 10.7 million 200000
Dec. 31, 2025 6.2 million -459000
Sept. 30, 2025 143000 90.5 million

CRNX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

CRNX

Price: $84.70

52 week price:
25.83
84.70

Earnings Per Share: -5.05 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 265100

Market Capitalization: 8.9 billion

Links: